Trials / Conditions / NASH With Fibrosis

NASH With Fibrosis

11 registered clinical trials studyying NASH With Fibrosis — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial NCT06138821	Pichamol Jirapinyo, MD, MPH	N/A
Active Not Recruiting	Non-invasive Tests for Non-alcoholic Steato-hepatitis NCT07502755	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	N/A
Not Yet Recruiting	AGED Diagnostics Liver Disease Assessment NCT06348563	Active Genomes Expressed Diagnostics, Corp	EARLY_Phase 1
Recruiting	A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic D NCT06215716	Akero Therapeutics, Inc	Phase 3
Terminated	Non-alcoholic Steatohepatitis Registry Platform Study NCT06123858	AstraZeneca	—
Completed	Dasatinib and Quercetin to Treat Fibrotic Non-alcoholic Fatty Liver Disease NCT05506488	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	Phase 1 / Phase 2
Completed	Single Dose ADME Study of [14C]-Rencofilstat in Healthy Male Subjects NCT05737433	Hepion Pharmaceuticals, Inc.	EARLY_Phase 1
Unknown	Effectiveness of Ultrasound in Liver Stiffness and Fat Quantification NCT06111859	King's College Hospital NHS Trust	N/A
Completed	A Study to Evaluate the Safety and Efficacy of Rencofilstat in Adult Subjects With NASH F3 NCT05461105	Hepion Pharmaceuticals, Inc.	Phase 2
Active Not Recruiting	Fibrosis Reduction in Non Alcoholic Steatohepatitis NCT05798702	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	N/A
Recruiting	Effectiveness of Bariatric Surgery for NAFLD/NASH NCT04366999	Beijing Friendship Hospital	—